Arul Joseph Duraisamy,Ruby Liu,Shruti Sureshkumar,Rajiv Rose,Lakshmanan Jagannathan,Cristina da Silva,Adam Coovadia,Vinish Ramachander,Sathyapriya Chandrasekar,Indu Raja,Manisha Sajnani,Sreekanth Muthu Selvaraj,Bhuvandeep Narang,Katayoon Darvishi,Amar Chand Bhayal,Lavanya Katikala,Fen Guo,Xiangwen Chen-Deutsch,Jorune Balciuniene,Zeqiang Ma,Babi Ramesh Reddy Nallamilli,Lora Bean,Christin Collins,Madhuri Hegde

Abstract:The genetically isolated yet heterogeneous and highly consanguineous Indian population has shown a higher prevalence of rare genetic disorders. However, there is a significant socioeconomic burden for genetic testing to be accessible to the general population. In the current study, we analyzed next-generation sequencing data generated through focused exome sequencing from individuals with different phenotypic manifestations referred for genetic testing to achieve a molecular diagnosis. We reported pathogenic or likely pathogenic variants in 280 of 833 cases with a diagnostic yield of 33.6%. Homozygous sequence and copy number variants were found as positive diagnostic findings in 131 cases (15.7%) because of the high consanguinity in the Indian population. No relevant findings related to reported phenotype were identified in 6.2% of the cases. Patients referred for testing due to metabolic disorder and neuromuscular disorder had higher diagnostic yields. Carrier testing of asymptomatic individuals with a family history of the disease, through focused exome sequencing, achieved positive diagnosis in 54 of 118 cases tested. We also reported copy number variants in trans with single-nucleotide variants and mitochondrial variants in a few of the cases. The diagnostic yield and the findings from this study signify that a focused exome test is a good lower-cost alternative for whole-exome and whole-genome sequencing and as a first-tier approach to genetic testing.

Focused Exome Sequencing Gives a High Diagnostic Yield in the Indian Subcontinent